Based on application, the PDx Models Market is further segmented into the preclinical drug
development & basic cancer research and biomarker analysis. In 2017, the preclinical drug development
and basic cancer research segment is expected to account for the largest share of the global PDx Models
Market. The large share of this segment can be mainly attributed to the increasing number of research
activities in the field of oncology drug research.
North America dominated the market in 2017
North America accounted for the largest share of the PDx Models Market in 2017, followed by Europe.
The large share of the North American PDx Models Market can be attributed to the growth in
biomedical research in the US, rising preclinical activities by CROs and pharmaceutical companies, and
growing stem cell research in Canada. However, the Asia Pacific market is projected to grow at the
highest CAGR during the forecast period, owing to strong research expenditure and the well-structured
CRO industry in China, growth in biomedical & medical research in Japan, rising pharmaceutical R&D
expenditure in India, and rising translational and biomedical research in Singapore.
Request Sample Report @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=121598251
List of Figures (34 Figures)
Figure 1 Global PDX Models Market: Research Methodology Steps
Figure 2 Sampling Frame: Primary Research
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Market Forecast Methodology
Figure 7 Data Triangulation Methodology
Figure 8 Global PDX Models Market, By Type (2017)
Figure 9 Global Patient Derived Xenograft Models Market, By Tumor Type (2017)
Figure 10 Global PDX Models Market, By Application
Read more: https://www.prnewswire.com/news-releases/patient-derived-xenograftpdx-models-
market-worth-1676-million-usd-by-2022-683462071.html